Clinical Trial Update: Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction [Phase 4]

View source ↗

Summary

Clinical trial update on reduced antithrombotic strategy for high bleeding risk myocardial infarction patients in a Phase 4 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Rikke Sorensen | Conditions: Myocardial Infarction | Phase 4 | Status: RECRUITING